Successful Regulatory Relationships Post-COVID-19 with Sponsors and FDRs

Robert Alfano, Compliance Director, Prime Therapeutics. Kenneth Nunez, Chief Compliance Officer, Provider Partners Health Plans.

February 2, 2021

  • Changes from COVID-19 on the regulatory relationship: More virtual, government has less resources, more expectations on Health Plans to comply and step up, more regulator sensitivity to CTMs due to beneficiary financial issues

  • Changes to Health Plan workforce: More remote- how to reach, teach, and enforce compliance in virtual settings, privacy issues, and security of data/workspaces in the "new normal"

  • Impacts to daily work and operations: FDRs impacted by shifting supply chain dynamics, applicability of COVID-19 additional and evolving regulations, and how to operationalize them in this new dynamic

This document is only available to subscribers